Bonnefoy J Y, Aubry J P, Peronne C, Wijdenes J, Banchereau J
J Immunol. 1987 May 1;138(9):2970-8.
In the present study a gamma 1 kappa monoclonal antibody, Mab 25, specific for the receptor for the Fc fragment of IgE on lymphocytes (Fc epsilon RL) was established. This antibody was generated after fusion of spleen cells from mice immunized with the EBV-transformed lymphoblastoid cell line RPMI 8866, which is known to express Fc epsilon RL at high density. Mab 25 inhibits strongly the binding of IgE to RPMI 8866 cells and to other Fc epsilon RL-positive EBV-transformed lymphoblastoid cell lines. A 50% inhibition of IgE binding was observed at a Mab 25 concentration of 10 ng/ml. The binding of IgE was also inhibited by Fab fragments of Mab 25, suggesting that the inhibition is not simply due to steric hindrance or to an eventual binding through its Fc portion. Mab 25 only binds to cell lines expressing Fc epsilon RL. Mab 25 immunoprecipitated a single polypeptide with an apparent m.w. of 42 Kd, pI 4.9. The membrane molecule bound to and eluted from a Mab 25 immunoabsorbent had the same apparent m.w. and pI as the Fc epsilon RL purified from an IgE immunoabsorbent. Additionally, when RPMI 8866 cell lysates were cleared with Mab 25, no Fc epsilon RL could be bound to or eluted from an IgE immunoabsorbent. Mab 25 was found to weakly bind to a minor proportion of blood (1 to 4%), tonsil (2 to 9%) and spleen (4 to 5%) mononuclear cells with a low intensity. By double fluorescence analysis, most of the Fc epsilon RL-positive cells were found to be CD 20-positive B lymphocytes. The staining pattern of Mab 25 and the biochemical characteristics of the antigen detected by Mab 25 were comparable to those of the CD 23 Mab. The four CD 23 Mab MHM 6, PL 13, HD 50, and Tü 1 were found to inhibit the binding of IgE. PL 13 was found to totally inhibit the binding of Mab 25 to RPMI 8866 cells, whereas Tü 1 and MHM 6 only partially inhibited Mab 25 binding. HD 50 was unable to block the binding of Mab 25. The finding that different CD 23/Fc epsilon RL-specific monoclonal antibodies recognizing distinct epitopes have in common the capacity of inhibiting the binding of IgE suggests that upon binding they induce a conformational alteration of the Fc epsilon RL resulting in a loss of the IgE binding capacity. In conclusion, our data demonstrate that the CD 23 antigen is a low affinity receptor for IgE on lymphocytes.
在本研究中,建立了一种针对淋巴细胞上IgE Fc片段受体(FcεRL)的γ1κ单克隆抗体Mab 25。该抗体是在用EBV转化的淋巴母细胞系RPMI 8866免疫的小鼠脾细胞融合后产生的,已知该细胞系高密度表达FcεRL。Mab 25强烈抑制IgE与RPMI 8866细胞以及其他FcεRL阳性的EBV转化淋巴母细胞系的结合。在Mab 25浓度为10 ng/ml时观察到IgE结合受到50%的抑制。Mab 25的Fab片段也抑制了IgE的结合,这表明这种抑制并非仅仅由于空间位阻或通过其Fc部分的最终结合。Mab 25仅与表达FcεRL的细胞系结合。Mab 25免疫沉淀出一条表观分子量为42 Kd、pI为4.9的单一多肽。与Mab 25免疫吸附剂结合并洗脱的膜分子与从IgE免疫吸附剂纯化的FcεRL具有相同的表观分子量和pI。此外,当用Mab 25清除RPMI 8866细胞裂解物时,没有FcεRL能够与IgE免疫吸附剂结合或从其洗脱。发现Mab 25与一小部分血液(1%至4%)、扁桃体(2%至9%)和脾脏(4%至5%)的单核细胞弱结合,强度较低。通过双重荧光分析,发现大多数FcεRL阳性细胞是CD 20阳性B淋巴细胞。Mab 25的染色模式以及Mab 25检测到的抗原的生化特征与CD 23单克隆抗体的相当。发现四种CD 23单克隆抗体MHM 6、PL 13、HD 50和Tü 1抑制IgE的结合。发现PL 13完全抑制Mab 25与RPMI 8866细胞的结合,而Tü 1和MHM 6仅部分抑制Mab 25的结合。HD 50无法阻断Mab 25的结合。不同的识别不同表位的CD 23/FcεRL特异性单克隆抗体都具有抑制IgE结合的能力,这一发现表明它们结合后会诱导FcεRL的构象改变,导致IgE结合能力丧失。总之,我们的数据表明CD 23抗原是淋巴细胞上IgE的低亲和力受体。